Stay updated with breaking news from Platform Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Polaris Now Enrolling in GBM AGILE, Registrational Phase 2-3 Adaptive Platform Trial for Patients with GlioblastomaPolaris lead biologic ADI-PEG 20 to be Evaluated Across Multiple International Trial SitesLARKSPUR, Calif.--(BUSINESS WIRE)--#GBMAGILE--Global Coalition for Adaptive Research (LARKSPUR, CA) and Polaris...
FACTS 7 includes new module for Platform Trial designsAUSTIN, Texas--(BUSINESS WIRE)--Berry Consultants, LLC announced today that FACTS 7 was released to existing users and is now available to all new clients. FACTS (Fixed and Adaptive Clinical Trial Simulator) is the most powerful, flexible, and fastest simulation...
OTTAWA, July 7 (Xinhua) -- Canadian Health Minister Jean-Yves Duclos announced Thursday an investment to create a pan-Canadian platform to advance research into the effectiveness and clinical challenges of new COVID-19 treatments in non-hospitalized patients.
Biohaven and Vigeo Now Enrolling in GBM AGILE, Registrational Phase 2-3 Adaptive Platform Trial to Evaluate Interventions for Patients With GlioblastomaLARKSPUR, Calif.--(BUSINESS WIRE)--#GBMAGILE--Global Coalition for Adaptive Research (LARKSPUR, CA), Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), and V...
Restrictions may be easing, but COVID-19 is still well and truly with us as much of Australia shivers through winter – our first with both COVID-19 and